Coronavirus likely to sideline 2020 policy changes for prescription pricing and 340B, while Medicare Part B reimbursement changes continue as planned

The coronavirus (COVID-19) outbreak is not only having a profound impact on our health care system, the American psyche, the stock market and the shelves at Costco — it will also affect what we can expect on drug pricing and 340B … [Read more...]

Time to Step Up Your Efforts at the State Level

Until recently, 340B program policy was largely debated in Washington, D.C.  But as Congress remains stalemated on drug pricing, state capitols have suddenly leapt to the forefront.  In this month’s column, I reflect on the … [Read more...]

Pro 340B Grassroots Organization Gains Momentum

One of the biggest challenges the 340B community has faced over the years is a lack of program knowledge at a local level. As I reported in my May column, Community Voices for 340B (CV340B) is the first grassroots organization solely … [Read more...]

More States Embrace 340B Program as a Win-Win for Taxpayers, Patients and the General Public

Since I started my column earlier this year, I have written a number of pieces on the unprecedented attention that the 340B program is facing in state capitols. One of the more exciting developments is the growing interest among states to partner … [Read more...]

AIR340B Quietly Steps Up Advocacy Efforts

For those who have been involved in 340B advocacy for a while, you will likely have heard of AIR340B. The Alliance for Integrity and Reform of 340B (AIR340B) was launched by the pharmaceutical industry in 2013. Its members include the trade … [Read more...]

Hospital specialty pharmacies offer a solution to growing problems: medication access & affordability

Over the past year, I have learned a lot about specialty pharmacy and its importance to 340B providers and patients.  A staggering 65% of the new drugs that came to market in 2018 were specialty drugs. These therapies can improve care and … [Read more...]

President’s Proposal to Require Drug Manufacturers to Disclose Prices in TV Ads

Ted Slafsky of Wexford Solutions Is Interviewed by Fox News Radio's daily podcast on the President's Proposal to Require Drug Manufacturers to Disclose Prices in TV Ads … [Read more...]

The View From the Nation’s Capital

This month’s column covers:  1) the significant uptick in drug manufacturer notices of overcharges to 340B providers and the importance of monitoring these developments. (2) The untold story of a little-known individual who played a … [Read more...]

A Welcome Addition to the 340B Debate

The pharmaceutical industry has successfully harnessed the power of patient groups to help in their advocacy efforts throughout state capitals and in Washington, D.C. According to the most recent data available, drug companies and their trade groups … [Read more...]

Why the President Should Hope He Loses ACA Court Battle

It has become axiomatic that Republican presidential candidates trounce their Democratic rivals in the South and other rural areas. The last time Democrats truly competed was in 1996, when Bill Clinton won such states as West Virginia, … [Read more...]